Changzhou Hengruiman Technology Co., Ltd – Trademark Portfolio

Entity Type: 99

Changzhou Hengruiman Technology Co., Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 20 (Furniture) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include MATTRELAX. The owner is based in Changzhou City.

No. 65, 1st F, Hua Luogeng Innovation Center Office Bldg., No. 90, Jintan Ave., Jintan Dist.

Changzhou City 213000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MATTRELAX
MATTRELAX
Registered 2025

Trademark Classifications

Changzhou Hengruiman Technology Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

20
Furniture (1 filing)

Furniture, mirrors, picture frames; goods of wood, cork, reed, cane, wicker

Frequently Asked Questions

How many trademarks does Changzhou Hengruiman Technology Co., Ltd have?

Changzhou Hengruiman Technology Co., Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Changzhou Hengruiman Technology Co., Ltd file in?

Changzhou Hengruiman Technology Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 20 (Furniture). Class 20 covers furniture, mirrors, picture frames; goods of wood, cork, reed, cane, wicker.

What are Changzhou Hengruiman Technology Co., Ltd's most well-known trademarks?

Changzhou Hengruiman Technology Co., Ltd's registered trademark portfolio includes well-known marks such as MATTRELAX. These are among 1 currently registered trademark in the portfolio.

What is Changzhou Hengruiman Technology Co., Ltd's trademark registration success rate?

Changzhou Hengruiman Technology Co., Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.